Skip to main content

Irrevocable Larson Family Investment Trust's Form 4 filing

Rockwell Medical, Inc.RMTI ยท filed Apr 15, 2025

Accession no.
0002021477-25-000007
Filed
Apr 15, 2025
Trade date
Apr 10-11, 2025
Filing delay
5 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 30 non-derivative transactions. Open-market purchases total $94.1K. It was filed 5 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Irrevocable Larson Family Investment TrustCIK 000202215710% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 10, 2025Common StockPPurchaseAcquired+4,000$1.06+$4,2403,474,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+4,000$1.08+$4,3203,478,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+2,000$1.05+$2,1003,480,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+2,000$1.08+$2,1603,482,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+2,000$1.08+$2,1603,484,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+6,000$1.07+$6,4203,490,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+2,000$1.07+$2,1403,492,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+7,000$1.07+$7,4903,499,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+10,000$1.10+$11,0003,509,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+2,000$1.04+$2,0803,511,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+2,000$1.05+$2,1003,513,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+2,000$1.05+$2,1003,515,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+2,000$1.04+$2,0803,517,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+4,000$1.06+$4,2403,521,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+2,000$1.06+$2,1203,523,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+2,000$1.07+$2,1403,525,000Direct
Apr 10, 2025Common StockPPurchaseAcquired+2,000$1.09+$2,1803,527,000Direct
Apr 11, 2025Common StockPPurchaseAcquired+2,000$1.08+$2,1603,529,000Direct
Apr 11, 2025Common StockPPurchaseAcquired+1,000$1.09+$1,0903,530,000Direct
Apr 11, 2025Common StockPPurchaseAcquired+2,000$1.07+$2,1403,532,000Direct
Apr 11, 2025Common StockPPurchaseAcquired+2,000$1.07+$2,1403,534,000Direct
Apr 11, 2025Common StockPPurchaseAcquired+2,000$1.08+$2,1603,536,000Direct
Apr 11, 2025Common StockPPurchaseAcquired+2,000$1.08+$2,1603,538,000Direct
Apr 11, 2025Common StockPPurchaseAcquired+2,000$1.08+$2,1603,540,000Direct
Apr 11, 2025Common StockPPurchaseAcquired+4,000$1.09+$4,3603,544,000Direct
Apr 11, 2025Common StockPPurchaseAcquired+1,500$1.09+$1,6353,545,500Direct
Apr 11, 2025Common StockPPurchaseAcquired+2,000$1.10+$2,2003,547,500Direct
Apr 11, 2025Common StockPPurchaseAcquired+2,000$1.06+$2,1203,549,500Direct
Apr 11, 2025Common StockPPurchaseAcquired+6,000$1.08+$6,4803,555,500Direct
Apr 11, 2025Common StockPPurchaseAcquired+2,000$1.09+$2,1803,557,500Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)